SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The economic burden of metastatic breast cancer: a U.S. managed care perspective
7 references·1 citing·27 second hop
The economic burden of metastatic breast cancer: a U.S. managed care perspective (2012)The economic burden of metastatic breast …Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Projections of the Cost of Ca…Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality (2011)Healthcare costs in women wit…Delivering affordable cancer care in high-income countries (2011)Delivering affordable cancer …The Costs of Treating Breast Cancer in the US (2009)The Costs of Treating Breast …Assessing the economic burden of breast cancer in a US managed care population (2007)Assessing the economic burden…Cost of Illness Associated with Metastatic Breast Cancer (2004)Cost of Illness Associated wi…Estimates of the Lifetime Direct Costs of Treatment for Metastatic Breast Cancer (2000)Estimates of the Lifetime Dir…Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review (2022)Economic and Humanistic Burde…Health Care Financing Review (1980)Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care (1995)The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)The costs of breast cancer prior to and following diagnosis (2010)INCIDENCE-BASED COST-OF-ILLNESS MODEL FOR METASTATIC BREAST CANCER IN THE UNITED STATES (2012)Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis (1995)Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data (2002)Cost of Care for Elderly Cancer Patients in the United States (2008)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Medical Care Costs Associated with Cancer Survivorship in the United States (2020)Cost-Effectiveness in Health and Medicine (1996)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)The out of pocket cost of breast cancer survivors: a review (2010)Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030 (2021)The price of innovation: new estimates of drug development costs (2003)Delivery of affordable and equitable cancer care in India (2014)Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity (2014)Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis (2016)The Distinction Between Cost and Charges (1982)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium (2008)Indirect costs associated with metastatic breast cancer (2013)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research (2011)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)
this work references cited by second hop

References

  • 2011Projections of the Cost of Cancer Care in the United States: 2010-20202,726 cited
  • 2011Delivering affordable cancer care in high-income countries720 cited
  • 2009The Costs of Treating Breast Cancer in the US119 cited
  • 2007Assessing the economic burden of breast cancer in a US managed care population94 cited
  • 2004Cost of Illness Associated with Metastatic Breast Cancer82 cited
  • 2011Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality69 cited
  • 2000Estimates of the Lifetime Direct Costs of Treatment for Metastatic Breast Cancer60 cited

Cited by

  • 2022Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review49 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work